These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1421372)

  • 21. Interactions between purified murine colony-stimulating factors (natural CSF-1, recombinant GM-CSF, and recombinant IL-3) on the in vitro proliferation of purified murine granulocyte-macrophage progenitor cells.
    Williams DE; Straneva JE; Cooper S; Shadduck RK; Waheed A; Gillis S; Urdal D; Broxmeyer HE
    Exp Hematol; 1987 Nov; 15(10):1007-12. PubMed ID: 3311784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant human stem cell factor enhances the formation of colonies by CD34+ and CD34+lin- cells, and the generation of colony-forming cell progeny from CD34+lin- cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor.
    Bernstein ID; Andrews RG; Zsebo KM
    Blood; 1991 Jun; 77(11):2316-21. PubMed ID: 1710148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin.
    Brugger W; Möcklin W; Heimfeld S; Berenson RJ; Mertelsmann R; Kanz L
    Blood; 1993 May; 81(10):2579-84. PubMed ID: 7683923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant murine granulocyte-macrophage (GM) colony-stimulating factor supports formation of GM and multipotential blast cell colonies in culture: comparison with the effects of interleukin-3.
    Koike K; Ogawa M; Ihle JN; Miyake T; Shimizu T; Miyajima A; Yokota T; Arai K
    J Cell Physiol; 1987 Jun; 131(3):458-64. PubMed ID: 3298286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro differentiation of human granulocyte/macrophage and erythroid progenitors: comparative analysis of the influence of recombinant human erythropoietin, G-CSF, GM-CSF, and IL-3 in serum-supplemented and serum-deprived cultures.
    Migliaccio G; Migliaccio AR; Adamson JW
    Blood; 1988 Jul; 72(1):248-56. PubMed ID: 2455571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiation and functional activity of human eosinophilic cells from an eosinophil HL-60 subline: response to recombinant hematopoietic growth factors.
    Fabian I; Lass M; Kletter Y; Golde DW
    Blood; 1992 Aug; 80(3):788-94. PubMed ID: 1379088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological properties in vitro of a combination of recombinant murine interleukin-3 and granulocyte-macrophage colony-stimulating factor.
    Riklis I; Kletter Y; Bleiberg I; Fabian I
    Eur J Haematol; 1989 Apr; 42(4):375-81. PubMed ID: 2656292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth and differentiation of eosinophils from human peripheral blood CD 34+ cells.
    Shalit M
    Allerg Immunol (Paris); 1997 Jan; 29(1):7-10. PubMed ID: 9025988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of recombinant granulocyte-macrophage colony-stimulating factor on murine thrombocytopoiesis in vitro and in vivo.
    Ishibashi T; Kimura H; Shikama Y; Uchida T; Kariyone S; Maruyama Y
    Blood; 1990 Apr; 75(7):1433-8. PubMed ID: 2180495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of bryostatin-1 on chronic myeloid leukaemia-derived haematopoietic progenitors.
    Thijsen SF; Schuurhuis GJ; van Oostveen JW; Theijsmeijer AP; van der Hem KG; Odding JH; Dräger AM; Ossenkoppele GJ
    Br J Cancer; 1999 Mar; 79(9-10):1406-12. PubMed ID: 10188883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of bryostatin 1 and rGM-CSF on the metabolism of 1-beta-D-arabinofuranosylcytosine in human leukaemic myeloblasts.
    Grant S; Jarvis WD; Turner AJ; Wallace HJ; Pettit GR
    Br J Haematol; 1992 Nov; 82(3):522-8. PubMed ID: 1486032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-gamma enhances factor-dependent myeloid proliferation of human CD34+ hematopoietic progenitor cells.
    Caux C; Moreau I; Saeland S; Banchereau J
    Blood; 1992 May; 79(10):2628-35. PubMed ID: 1375107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth of human hemopoietic colonies in response to recombinant gibbon interleukin 3: comparison with human recombinant granulocyte and granulocyte-macrophage colony-stimulating factor.
    Messner HA; Yamasaki K; Jamal N; Minden MM; Yang YC; Wong GG; Clark SC
    Proc Natl Acad Sci U S A; 1987 Oct; 84(19):6765-9. PubMed ID: 3498941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
    Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
    Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro effects of bryostatin 1 on the metabolism and cytotoxicity of 1-beta-D-arabinofuranosylcytosine in human leukemia cells.
    Grant S; Boise L; Westin E; Howe C; Pettit GR; Turner A; McCrady C
    Biochem Pharmacol; 1991 Jul; 42(4):853-67. PubMed ID: 1867641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of recombinant and purified hematopoietic growth factors on human megakaryocyte colony formation.
    Bruno E; Briddell R; Hoffman R
    Exp Hematol; 1988 Jun; 16(5):371-7. PubMed ID: 2453373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD34-expressing human thymocyte precursors proliferate in response to interleukin-7 but have lost myeloid differentiation potential.
    Schmitt C; Ktorza S; Sarun S; Blanc C; De Jong R; Debre P
    Blood; 1993 Dec; 82(12):3675-85. PubMed ID: 7505122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transient expression of PU.1 commits multipotent progenitors to a myeloid fate whereas continued expression favors macrophage over granulocyte differentiation.
    McIvor Z; Hein S; Fiegler H; Schroeder T; Stocking C; Just U; Cross M
    Exp Hematol; 2003 Jan; 31(1):39-47. PubMed ID: 12543105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiation of ara-C-induced apoptosis by the protein kinase C activator bryostatin 1 in human leukemia cells (HL-60) involves a process dependent upon c-Myc.
    Chelliah J; Freemerman AJ; Wu-Pong S; Jarvis WD; Grant S
    Biochem Pharmacol; 1997 Sep; 54(5):563-73. PubMed ID: 9337072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.